| prevalence of antibodies against hepatitis c virus infection among health care workers in stockholm. | the prevalence of hepatitis c virus (hcv) markers was investigated among health care staff with a high rate of exposure to blood or needle-stick injuries. after screening sera in pools of 10 at a time and individual testing of all reactive pools, totally 6 of 880 (0.7%; 95% confidence interval, 0.25-14.8%) were positive for anti-hcv, a figure of the same order as that found among swedish first-time blood donors. among the seropositives, all of five evaluable had been exposed to blood and four of ... | 1994 | 8047813 |
| prevalence and risk factors for htlv-ii infection in 913 injecting drug users in stockholm, 1994. | the prevalence and risk factors for acquisition of human t-cell lymphotropic virus type i and ii (htlv-i and ii) were investigated in a prospective study of 913 injecting drug users (idus) in stockholm in 1994. epidemiologic data were recorded, and blood samples were tested for antibodies against htlv-i and htlv-ii; human immunodeficiency virus (hiv) types 1 and 2; and hepatitis a (hav), b (hbv), c (hcv), and d (hdv). positive serologic results for htlv were confirmed by western blot (wb) and po ... | 1997 | 9342259 |
| hepatitis c infection among injection drug users in stockholm sweden: prevalence and gender. | hepatitis c virus (hcv) infection is widespread among injection drug users. young women seem to be at higher risk of acquiring hcv. to optimize future intervention and prevention measures, we studied the epidemiology of human immunodeficiency virus (hiv), hepatitis b (hbv), and hcv infection among men and women. inclusion criteria for this cross-sectional multicentre study were: history of ever injecting drugs, age > 18 y, and no previous hiv diagnosis. in 310 participants, plasma/serum samples ... | 2009 | 19521924 |
| prevalence of human t-lymphotropic virus type 1 and 2 infection in sweden. | prevalence data on human t-lymphotropic virus types 1 and 2 (htlv-1/2) in sweden have not been updated since 1995. the seroprevalence among blood donors at that time was 0.2/10,000. a few years earlier, a high prevalence of htlv-2 was found in intravenous drug users (idus) in stockholm (3.4%). the objective of this study was to update information on the seroprevalence of htlv in several study groups. | 2012 | 22803699 |
| liver transplantation for hcv cirrhosis at karolinska university hospital huddinge, stockholm. | hepatitis c virus (hcv)-induced cirrhosis is the major indication for liver transplantation globally, and an increasing indication for liver transplantation in sweden. we have retrospectively examined the 120 patients transplanted for hcv cirrhosis from 1987 through 2005, including 11 who received more than one graft. the 1-, 3-, and 5-year postoperative survivals for all patients transplanted for hcv with or without hepatocellular cancer (hcc) were 77%, 66%, and 53%, respectively. hcv patients ... | 2006 | 17098036 |
| seroconversion to hepatitis c virus in dialysis patients: a retrospective and prospective study. | the prevalence and incidence of hepatitis c virus (hcv) infections were studied in 236 dialysis patients and related to clinical data at two hospitals in stockholm, sweden. patients were followed during 12 months and tested by 1st- and 2nd-generation anti-hcv assays. time of seroconversion to hcv could be determined by retrospective analysis of stored serum samples. a total of 36 (15%) patients were anti-hcv positive. time of seroconversion could be determined for 23 patients and was in the majo ... | 1993 | 7692314 |
| seroconversion to hepatitis c virus antibodies in patients with acute posttransfusion non-a, non-b hepatitis in sweden. | seventy-four patients in 1978 and 316 in 1986, all transfused during open-heart surgery in stockholm, sweden, were studied prospectively for the development of posttransfusion non-a, non-b (nanb) hepatitis, seroconversion to hepatitis c virus antibodies (anti-hcv) (c-100), time lag to seroconversion to anti-hcv and outcome of posttransfusion nanb/c hepatitis. anti-hcv was tested up to six months after transfusions in patients from 1978 and up to one year after transfusions in patients from 1986. ... | 1991 | 1666063 |
| seroconversion to hepatitis c virus antibodies in patients with acute posttransfusion non-a, non-b hepatitis in sweden with a second generation test. | 28 patients with posttransfusion non-a, non-b (nanb) hepatitis in stockholm, sweden, were studied for seroconversion to hepatitis c virus antibodies (anti-hcv) and time lag to seroconversion by first and second generation tests. 15/28 patients (54%) seroconverted to anti-hcv with a first generation anti-hcv elisa using c100-3 from the nonstructural (ns) region 4 of the hcv genome and 23 (82%) with a second generation anti-hcv elisa including also antigens from the core and ns3 regions of the hcv ... | 1992 | 1375390 |
| limited spread of hepatitis c among hiv-negative men who have sex with men in stockholm, sweden. | reported cases of hepatitis c (hcv) have been increasing among hiv-positive men who have sex with men (msm) in many cities worldwide, including stockholm, sweden. this study was performed in order to see whether there is also an increase of hcv among hiv-negative msm. a total number of 1008 msm attending a clinic for sexually transmitted infections (sti) were screened for hcv. a confirmed positive hcv antibody screening test was found in five cases. two of these also tested positive for hcv-rna. ... | 2014 | 24352124 |
| prevalence of hepatitis c and pre-testing awareness of hepatitis c status in 1500 consecutive pwid participants at the stockholm needle exchange program. | people who inject drugs (pwid) are the driving force of the hepatitis c virus (hcv) epidemic. still, treatment is scarcely offered and the awareness of hcv status in pwid is poor. prevention includes clean needles, syringes and other paraphernalia. hcv awareness was investigated in 1500 pwid in a needle exchange program (nep) in stockholm, sweden, together with hcv prevalence, and time to hcv infection after start of injection drug use. | 2017 | 28574295 |
| risk behaviour determinants among people who inject drugs in stockholm, sweden over a 10-year period, from 2002 to 2012. | people who inject drugs (pwid) frequently engage in injection risk behaviours exposing them to blood-borne infections. understanding the underlying causes that drive various types and levels of risk behaviours is important to better target preventive interventions. | 2017 | 28814336 |
| knowledge of status and assessment of personal health consequences with hepatitis c are not enough to change risk behaviour among injecting drug users in stockholm county, sweden. | this was a multicentre study with risk perception as the theoretical framework, investigating if risk behaviours change when injecting drug users (idus) are aware of their hepatitis c virus (hcv) status and had assessed the health consequences with hcv infection. two hundred and thirteen participants aged 15-40 y were analysed. sharing of needles and of other injecting equipment were common both among participants who reported hcv-positive status (74%, 95% confidence interval (ci) 65.3-80.1%) an ... | 2009 | 19688640 |
| methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. | to determine the total mortality related to the stockholm methadone programme during the period 1988-2000, both the mortality related to the treatment and fatal methadone intoxications in the stockholm area during the same period. | 2007 | 17298648 |
| the prevalence of hepatitis c in patients with porphyria cutanea tarda in stockholm, sweden. | in many countries hepatitis c virus infection has been considered a major factor triggering overt porphyria cutanea tarda. the prevalence of hepatitis c virus infection was retrospectively studied in 87 patients who during a period of 11 years were diagnosed with porphyria cutanea tarda in stockholm. among patients with the sporadic form of porphyria cutanea tarda, the prevalence of hepatitis c virus infection was 36.4%. as hepatitis c virus infection may today be successfully treated and as the ... | 2005 | 15823914 |
| hepatitis c among injecting drug users is two times higher in stockholm, sweden than in rotterdam, the netherlands. | this study assessed risk behavior and preventive measures for hepatitis c among injecting drug users in rotterdam, the netherlands (452 participants, 2002-2003) and stockholm, sweden (310 participants, 2004-2006), two cities with contrasting drug policies. uni- and multivariate logistic regression models were used. we found that the prevalence of hepatitis c was almost two times higher in participants from stockholm than in participants from rotterdam, even after adjustment for sex sharing parap ... | 2013 | 23750711 |